• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

噻唑-磺胺衍生物的合成、DFT 研究、分子对接和作为潜在阿尔茨海默病抑制剂的生物活性评价。

Synthesis, DFT Studies, Molecular Docking and Biological Activity Evaluation of Thiazole-Sulfonamide Derivatives as Potent Alzheimer's Inhibitors.

机构信息

Department of Chemistry, Hazara University, Mansehra 21120, Pakistan.

Department of Chemistry, University of Okara, Okara 56130, Pakistan.

出版信息

Molecules. 2023 Jan 5;28(2):559. doi: 10.3390/molecules28020559.

DOI:10.3390/molecules28020559
PMID:36677616
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9860845/
Abstract

Alzheimer's disease is a major public brain condition that has resulted in many deaths, as revealed by the World Health Organization (WHO). Conventional Alzheimer's treatments such as chemotherapy, surgery, and radiotherapy are not very effective and are usually associated with several adverse effects. Therefore, it is necessary to find a new therapeutic approach that completely treats Alzheimer's disease without many side effects. In this research project, we report the synthesis and biological activities of some new thiazole-bearing sulfonamide analogs (-) as potent anti-Alzheimer's agents. Suitable characterization techniques were employed, and the density functional theory (DFT) computational approach, as well as in-silico molecular modeling, has been employed to assess the electronic properties and anti-Alzheimer's potency of the analogs. All analogs exhibited a varied degree of inhibitory potential, but analog was found to have excellent potency (IC = 0.10 ± 0.05 µM for AChE) and (IC = 0.20 ± 0.050 µM for BuChE) as compared to the reference drug donepezil (IC = 2.16 ± 0.12 µM and 4.5 ± 0.11 µM). The structure-activity relationship was established, and it mainly depends upon the nature, position, number, and electron-donating/-withdrawing effects of the substituent/s on the phenyl rings.

摘要

阿尔茨海默病是一种主要的公众脑部疾病,世界卫生组织(WHO)已经揭示出其导致了许多死亡病例。常规的阿尔茨海默病治疗方法,如化疗、手术和放疗,效果并不十分显著,而且通常伴有多种不良反应。因此,有必要寻找一种新的治疗方法,以完全治愈阿尔茨海默病,且没有许多副作用。在这个研究项目中,我们报告了一些新型含噻唑的磺酰胺类似物(-)的合成和生物活性,这些类似物作为有效的抗阿尔茨海默病药物。采用了合适的表征技术,并且采用了密度泛函理论(DFT)计算方法和计算机模拟分子建模,以评估类似物的电子性质和抗阿尔茨海默病的潜力。所有类似物都表现出不同程度的抑制潜力,但与参比药物多奈哌齐(IC = 0.10 ± 0.05 µM 对 AChE,IC = 0.20 ± 0.050 µM 对 BuChE)相比,类似物 显示出了极好的活性(IC = 0.10 ± 0.05 µM 对 AChE,IC = 0.20 ± 0.050 µM 对 BuChE)。建立了构效关系,其主要取决于取代基在苯环上的性质、位置、数量和供电子/吸电子效应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/6d2f8f315f1a/molecules-28-00559-g017a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/69ea690486dc/molecules-28-00559-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/c2e3edc7a5cf/molecules-28-00559-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/7a6ab63edf59/molecules-28-00559-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/1d1925920a6d/molecules-28-00559-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/1b9602534a70/molecules-28-00559-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/8865817759d3/molecules-28-00559-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/f120f6eabdea/molecules-28-00559-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/1c95213a54e4/molecules-28-00559-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/abc3a4f68f9b/molecules-28-00559-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/e170ef194262/molecules-28-00559-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/47705b99abef/molecules-28-00559-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/7f2563154501/molecules-28-00559-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/63067bcc2288/molecules-28-00559-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/eff668aa2f7c/molecules-28-00559-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/bb979fd51dc3/molecules-28-00559-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/ba970c154436/molecules-28-00559-g015a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/0ad494134e62/molecules-28-00559-g016a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/6d2f8f315f1a/molecules-28-00559-g017a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/69ea690486dc/molecules-28-00559-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/c2e3edc7a5cf/molecules-28-00559-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/7a6ab63edf59/molecules-28-00559-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/1d1925920a6d/molecules-28-00559-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/1b9602534a70/molecules-28-00559-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/8865817759d3/molecules-28-00559-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/f120f6eabdea/molecules-28-00559-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/1c95213a54e4/molecules-28-00559-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/abc3a4f68f9b/molecules-28-00559-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/e170ef194262/molecules-28-00559-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/47705b99abef/molecules-28-00559-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/7f2563154501/molecules-28-00559-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/63067bcc2288/molecules-28-00559-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/eff668aa2f7c/molecules-28-00559-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/bb979fd51dc3/molecules-28-00559-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/ba970c154436/molecules-28-00559-g015a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/0ad494134e62/molecules-28-00559-g016a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b2/9860845/6d2f8f315f1a/molecules-28-00559-g017a.jpg

相似文献

1
Synthesis, DFT Studies, Molecular Docking and Biological Activity Evaluation of Thiazole-Sulfonamide Derivatives as Potent Alzheimer's Inhibitors.噻唑-磺胺衍生物的合成、DFT 研究、分子对接和作为潜在阿尔茨海默病抑制剂的生物活性评价。
Molecules. 2023 Jan 5;28(2):559. doi: 10.3390/molecules28020559.
2
Multipotent Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease: Synthesis, Biological Analysis and Molecular Docking Study of Benzimidazole-Based Thiazole Derivatives.多能胆碱酯酶抑制剂治疗阿尔茨海默病:基于苯并咪唑噻唑衍生物的合成、生物学分析和分子对接研究。
Molecules. 2022 Sep 18;27(18):6087. doi: 10.3390/molecules27186087.
3
Design, Synthesis, In Vitro Biological Evaluation and In Silico Molecular Docking Study of Benzimidazole-Based Oxazole Analogues: A Promising Acetylcholinesterase and Butyrylcholinesterase Inhibitors.苯并咪唑基噁唑类似物的设计、合成、体外生物评价及计算机分子对接研究:一种有前途的乙酰胆碱酯酶和丁酰胆碱酯酶抑制剂。
Molecules. 2023 Oct 10;28(20):7015. doi: 10.3390/molecules28207015.
4
Ultrasound-Assisted Synthesis of Piperidinyl-Quinoline Acylhydrazones as New Anti-Alzheimer's Agents: Assessment of Cholinesterase Inhibitory Profile, Molecular Docking Analysis, and Drug-like Properties.超声辅助合成哌啶基-喹啉甲酰腙类化合物作为新型抗阿尔茨海默病药物:乙酰胆碱酯酶抑制谱评估、分子对接分析和类药性评价。
Molecules. 2023 Feb 24;28(5):2131. doi: 10.3390/molecules28052131.
5
Synthesis of New Triazole-Based Thiosemicarbazone Derivatives as Anti-Alzheimer's Disease Candidates: Evidence-Based In Vitro Study.新型三氮唑基缩硫代氨基脲衍生物的合成及其作为抗阿尔茨海默病候选物的体外研究。
Molecules. 2022 Dec 20;28(1):21. doi: 10.3390/molecules28010021.
6
Design, synthesis, biological evaluation, and molecular dynamics of novel cholinesterase inhibitors as anti-Alzheimer's agents.新型乙酰胆碱酯酶抑制剂的设计、合成、生物评价及作为抗阿尔茨海默病药物的分子动力学研究。
Arch Pharm (Weinheim). 2019 Jul;352(7):e1800352. doi: 10.1002/ardp.201800352. Epub 2019 May 28.
7
Synthesis, molecular docking, acetylcholinesterase and butyrylcholinesterase inhibitory potential of thiazole analogs as new inhibitors for Alzheimer disease.噻唑类似物作为阿尔茨海默病新抑制剂的合成、分子对接、乙酰胆碱酯酶和丁酰胆碱酯酶抑制潜力
Bioorg Chem. 2015 Oct;62:106-16. doi: 10.1016/j.bioorg.2015.08.002. Epub 2015 Aug 19.
8
Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.新型联苯双磺酰胺类乙酰胆碱酯酶和丁酰胆碱酯酶抑制剂的合成、生物评价及分子模拟研究。
Bioorg Chem. 2016 Feb;64:13-20. doi: 10.1016/j.bioorg.2015.11.002. Epub 2015 Nov 10.
9
Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.吡啶磺酰胺作为一种小分子有机药物,具有治疗 II 型糖尿病和阿尔茨海默病的潜力:体外研究对抗酵母 α-葡萄糖苷酶、乙酰胆碱酯酶和丁酰胆碱酯酶。
Bioorg Chem. 2015 Dec;63:64-71. doi: 10.1016/j.bioorg.2015.09.008. Epub 2015 Sep 30.
10
Pyrimidine-morpholine hybrids as potent druggable therapeutics for Alzheimer's disease: Synthesis, biochemical and in silico analyses.嘧啶吗啉杂合体作为治疗阿尔茨海默病的有效药物:合成、生化和计算分析。
Bioorg Chem. 2023 Dec;141:106868. doi: 10.1016/j.bioorg.2023.106868. Epub 2023 Sep 16.

引用本文的文献

1
Furan-thiazole hydrazone scaffolds as promising antitubercular and antibacterial agents: synthesis, characterization, bioevaluation and computational analysis.呋喃-噻唑腙支架作为有前景的抗结核和抗菌剂:合成、表征、生物评价及计算分析
RSC Adv. 2025 Aug 22;15(36):30001-30025. doi: 10.1039/d5ra04238k. eCollection 2025 Aug 18.
2
DFT Investigations and Molecular Docking as Potent Inhibitors of SARS-CoV-2 Main Protease of Novel Pyrimidine Dione Derivatives.密度泛函理论研究与分子对接:新型嘧啶二酮衍生物作为严重急性呼吸综合征冠状病毒2主蛋白酶的有效抑制剂
Biochem Res Int. 2025 Aug 11;2025:7961294. doi: 10.1155/bri/7961294. eCollection 2025.
3

本文引用的文献

1
Mechanism of zinc ejection by disulfiram in nonstructural protein 5A.二硫代氨基甲酸酯通过非结构蛋白 5A 排出锌的机制。
Phys Chem Chem Phys. 2021 Jun 2;23(21):12204-12215. doi: 10.1039/d0cp06360f.
2
Predicting Multi-Interfacial Binding Mechanisms of NLRP3 and ASC Pyrin Domains in Inflammasome Activation.预测 NLRP3 和 ASC 吡喃结构域在炎症小体激活中的多界面结合机制。
ACS Chem Neurosci. 2021 Feb 17;12(4):603-612. doi: 10.1021/acschemneuro.0c00519. Epub 2021 Jan 27.
3
Design, synthesis, biological evaluation, and docking study of novel dual-acting thiazole-pyridiniums inhibiting acetylcholinesterase and β-amyloid aggregation for Alzheimer's disease.
Therapeutic potential inhibitor for dipeptidyl peptidase IV in diabetic type 2: in silico approaches.
2型糖尿病中双肽基肽酶IV的治疗性潜在抑制剂:计算机模拟方法
3 Biotech. 2025 Jan;15(1):24. doi: 10.1007/s13205-024-04200-6. Epub 2024 Dec 27.
4
Anti colorectal cancer activity and in silico studies of novel pyridine nortopsentin analog as cyclin dependent kinase 6 inhibitor.新型吡啶 nortopsentin 类似物作为细胞周期蛋白依赖性激酶 6 抑制剂的抗结直肠癌活性及计算机模拟研究。
Sci Rep. 2024 Nov 1;14(1):26327. doi: 10.1038/s41598-024-75411-3.
5
Thiazolation of phenylthiosemicarbazone to access new thiazoles: anticancer activity and molecular docking.噻唑化苯硫代缩氨基脲以获得新的噻唑类化合物:抗癌活性和分子对接。
Future Med Chem. 2024;16(12):1219-1237. doi: 10.1080/17568919.2024.2342668. Epub 2024 May 15.
6
Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants.阿尔茨海默病的药物治疗靶点综述及其传统药用植物管理
Degener Neurol Neuromuscul Dis. 2024 May 19;14:47-74. doi: 10.2147/DNND.S452009. eCollection 2024.
7
Butterfly Effect in Cytarabine: Combined NMR-NQR Experiment, Solid-State Computational Modeling, Quantitative Structure-Property Relationships and Molecular Docking Study.阿糖胞苷中的蝴蝶效应:核磁共振 - 核四极共振联合实验、固态计算建模、定量结构 - 性质关系及分子对接研究
Pharmaceuticals (Basel). 2024 Mar 29;17(4):445. doi: 10.3390/ph17040445.
8
Synthesis, In Vitro Biological Evaluation and Molecular Modeling of Benzimidazole-Based Pyrrole/Piperidine Hybrids Derivatives as Potential Anti-Alzheimer Agents.基于苯并咪唑的吡咯/哌啶杂化衍生物作为潜在抗阿尔茨海默病药物的合成、体外生物学评价及分子模拟
Pharmaceuticals (Basel). 2024 Mar 24;17(4):410. doi: 10.3390/ph17040410.
9
Synthesis, ADMET prediction analysis, and pharmacological evaluation of sulfonamide derivatives tethered with pyrazole or pyridine as anti-diabetic and anti-Alzheimer's agents.作为抗糖尿病和抗阿尔茨海默病药物的、与吡唑或吡啶相连的磺酰胺衍生物的合成、ADMET预测分析及药理学评价
Saudi Pharm J. 2024 May;32(5):102025. doi: 10.1016/j.jsps.2024.102025. Epub 2024 Mar 12.
10
Sulfonamide Derivatives: Recent Compounds with Potent Anti-alzheimer's Disease Activity.磺胺衍生物:具有强效抗老年痴呆症活性的新型化合物。
Cent Nerv Syst Agents Med Chem. 2024;24(1):82-104. doi: 10.2174/0118715249278489231128042135.
新型噻唑-吡啶鎓双靶标抑制剂的设计、合成、生物评价及对接研究,用于阿尔茨海默病的乙酰胆碱酯酶和β-淀粉样蛋白聚集抑制。
Bioorg Chem. 2020 Oct;103:104186. doi: 10.1016/j.bioorg.2020.104186. Epub 2020 Aug 26.
4
Synthesis, in vitro urease inhibitory potential and molecular docking study of benzofuran-based-thiazoldinone analogues.基于苯并呋喃噻唑啉酮类似物的合成、体外脲酶抑制活性及分子对接研究。
Sci Rep. 2020 Jun 30;10(1):10673. doi: 10.1038/s41598-020-67414-7.
5
Investigation of Some Antiviral -Heterocycles as COVID 19 Drug: Molecular Docking and DFT Calculations.研究某些作为 COVID-19 药物的抗病毒杂环化合物:分子对接和 DFT 计算。
Int J Mol Sci. 2020 May 30;21(11):3922. doi: 10.3390/ijms21113922.
6
Synthesis of calix[4]azacrown substituted sulphonamides with antioxidant, acetylcholinesterase, butyrylcholinesterase, tyrosinase and carbonic anhydrase inhibitory action.合成具有抗氧化、乙酰胆碱酯酶、丁酰胆碱酯酶、酪氨酸酶和碳酸酐酶抑制活性的杯[4]氮杂冠取代磺酰胺。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1215-1223. doi: 10.1080/14756366.2020.1765166.
7
Synthesis, In vitro α-Glucosidase Inhibitory Potential and Molecular Docking Studies of 2-Amino-1,3,4-Oxadiazole Derivatives.2-氨基-1,3,4-恶二唑衍生物的合成、体外α-葡萄糖苷酶抑制活性及分子对接研究。
Med Chem. 2020;16(6):724-734. doi: 10.2174/1573406415666190612150447.
8
Design and synthesis of donepezil analogues as dual AChE and BACE-1 inhibitors.设计并合成多奈哌齐类似物作为双重乙酰胆碱酯酶和 BACE-1 抑制剂。
Bioorg Chem. 2018 Oct;80:245-252. doi: 10.1016/j.bioorg.2018.06.031. Epub 2018 Jun 25.
9
New anticancer drug candidates sulfonamides as selective hCA IX or hCA XII inhibitors.新型抗癌药物候选物磺胺类药物作为选择性 hCAIX 或 hCAXII 抑制剂。
Bioorg Chem. 2018 Apr;77:411-419. doi: 10.1016/j.bioorg.2018.01.021. Epub 2018 Jan 16.
10
Novel aminopyrimidinyl benzimidazoles as potentially antimicrobial agents: Design, synthesis and biological evaluation.新型氨基嘧啶基苯并咪唑作为潜在抗菌剂:设计、合成及生物学评价
Eur J Med Chem. 2018 Jan 1;143:66-84. doi: 10.1016/j.ejmech.2017.11.027. Epub 2017 Nov 10.